Literature DB >> 15131761

Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes.

Takahiro Kawasaki1, Nobuyuki Ogata, Hiroshi Akanuma, Tadashi Sakai, Hiroyuki Watanabe, Kaoru Ichiyanagi, Toshikazu Yamanouchi.   

Abstract

The aim of the present study was to investigate the association of fructose on microangiopathy in patients with diabetes. Postprandial plasma fructose concentrations and postprandial plasma glucose concentrations were simultaneously measured 3 times within a 24-hour period (2 hours after each meal) in 38 patients with type 2 diabetes that had been admitted to the hospital. The mean postprandial plasma fructose concentrations (MPPF) and the mean postprandial plasma glucose concentrations (MPPG) were calculated. Fructose was measured by gas chromatography-mass spectrometry (GCMS). Based solely on MPPF, we were able to divide the patients into three groups: the high MPPF (31.9 +/- 6.5 micromol/L) group (n = 12), the middle MPPF (21.2 +/- 1.8 micromol/L) group (n = 13), and the low MPPF (15.2 +/- 2.4 micromol/L) group (n = 13). Prevalence and degree of retinopathy and nephropathy were then evaluated in the 3 different groups. A significant correlation was observed in the prevalence of proliferative diabetic retinopathy (PDR) among the 3 MPPF groups (P =.024). The prevalence of PDR was higher in the high MPPF group (75.0%) than in the middle and low MPPF groups (23.1% and 38.5%, respectively). Although not significantly different statistically, the prevalence of all degrees of retinopathy showed a tendency to be higher in the high MPPF group (83.3%) than in the middle and low MPPF groups (46.2% and 46.2%, respectively) (P =.081). Nephropathy prevalence also showed a tendency to be higher in the high MPPF group (66.7%) than in the middle and low MPPF groups (38.5% and 30.8%, respectively), although the differences were not significant. The prevalence of clinical albuminuria was not significantly different among the 3 groups, but there was a tendency for it to be higher in the low MPPF group (30.8%) than in the high and middle MPPF groups (16.7% and 0%, respectively). No significant differences in glycemic indicators and mean duration of diabetes were observed among the 3 groups. The increased prevalence of retinopathy in the high MPPF group suggests that fructose is associated with retinopathy in patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131761     DOI: 10.1016/j.metabol.2003.12.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Effect of dietary fructose on portal and systemic serum fructose levels in rats and in KHK-/- and GLUT5-/- mice.

Authors:  Chirag Patel; Keiichiro Sugimoto; Veronique Douard; Ami Shah; Hiroshi Inui; Toshikazu Yamanouchi; Ronaldo P Ferraris
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-27       Impact factor: 4.052

2.  Elevated Serum Sorbitol and not Fructose in Type 2 Diabetic Patients.

Authors:  Gregory M Preston; Roberto A Calle
Journal:  Biomark Insights       Date:  2010-05-04

3.  Measurement of glucose and fructose in clinical samples using gas chromatography/mass spectrometry.

Authors:  Paulin N Wahjudi; Mary E Patterson; Shu Lim; Jennifer K Yee; Catherine S Mao; W-N Paul Lee
Journal:  Clin Biochem       Date:  2009-09-08       Impact factor: 3.281

Review 4.  Dietary sugars: their detection by the gut-brain axis and their peripheral and central effects in health and diseases.

Authors:  Melissa Ochoa; Jean-Paul Lallès; Charles-Henri Malbert; David Val-Laillet
Journal:  Eur J Nutr       Date:  2014-10-09       Impact factor: 5.614

5.  Bioactivity-Guided Identification of Botanical Inhibitors of Ketohexokinase.

Authors:  MyPhuong T Le; Miguel A Lanaspa; Christina M Cicerchi; Jatinder Rana; Jeffrey D Scholten; Brandi L Hunter; Christopher J Rivard; R Keith Randolph; Richard J Johnson
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240

6.  Microbiome Alteration in Type 2 Diabetes Mellitus Model of Zebrafish.

Authors:  Fumiyoshi Okazaki; Liqing Zang; Hiroko Nakayama; Zhen Chen; Zi-Jun Gao; Hitoshi Chiba; Shu-Ping Hui; Takahiko Aoki; Norihiro Nishimura; Yasuhito Shimada
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

7.  SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose.

Authors:  Taku Fukuzawa; Masanori Fukazawa; Otoya Ueda; Hideaki Shimada; Aki Kito; Mami Kakefuda; Yosuke Kawase; Naoko A Wada; Chisato Goto; Naoshi Fukushima; Kou-Ichi Jishage; Kiyofumi Honda; George L King; Yoshiki Kawabe
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

Review 8.  Intestinal Fructose and Glucose Metabolism in Health and Disease.

Authors:  Beatriz Merino; Cristina M Fernández-Díaz; Irene Cózar-Castellano; German Perdomo
Journal:  Nutrients       Date:  2019-12-29       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.